Everyday Health (EVDY) 10-Q/A 10 Jun 14 2014 Q1 Quarterly report (amended) Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2014	9-May-14
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'Everyday Health, Inc.	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	30,091,942
Amendment Flag	'false	'
Entity Central Index Key	'0001358483	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$14,770	$16,242
Accounts receivable, net of allowance for doubtful accounts of $530, $642 and $642 as of December 31, 2013, March 31, 2014 and pro forma March 31, 2014, respectively	38,223	49,373
Deferred tax asset	133	133
Prepaid expenses and other current assets	9,627	7,822
Total current assets	62,753	73,570
Property and equipment, net	21,751	21,095
Goodwill	82,153	82,153
Intangible assets, net	9,190	9,735
Other assets	4,910	5,729
Total assets	180,757	192,282
Current liabilities:	'	'
Accounts payable	6,754	8,459
Accrued expenses	18,094	25,919
Deferred revenue	7,376	6,808
Current portion of long-term debt	1,500	1,333
Other current liabilities	929	830
Total current liabilities	34,653	43,349
Long-term debt	70,800	70,000
Deferred tax liabilities	5,440	5,199
Other long-term liabilities	5,224	4,937
Redeemable convertible preferred stock (Series A-G), net of expenses, $0.01 par value: 27,204,144 shares authorized at December 31, 2013 and March 31, 2014; 26,820,270 shares issued and outstanding at December 31, 2013 and March 31, 2014 (aggregate liquidation value of $114,627 at March 31, 2014); no shares issued and outstanding at March 31, 2014, pro forma	158,766	158,766
Stockholders’ equity (deficit):	'	'
Common stock, $0.01 par value: 45,000,000 shares authorized at December 31, 2013 and March 31, 2014; 5,366,478 and 5,545,768 shares issued and outstanding at December 31, 2013 and March 31, 2014, respectively; 30,091,942 shares issued and outstanding at March 31, 2014, pro forma	56	54
Treasury stock	-55	-55
Additional paid-in capital	37,326	33,726
Accumulated deficit	-131,453	-123,694
Total stockholders’ equity (deficit)	-94,126	-89,969
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	180,757	192,282
Pro Forma [Member]	'	'
Current assets:	'	'
Cash and cash equivalents	89,551	'
Accounts receivable, net of allowance for doubtful accounts of $530, $642 and $642 as of December 31, 2013, March 31, 2014 and pro forma March 31, 2014, respectively	38,223	'
Deferred tax asset	133	'
Prepaid expenses and other current assets	6,865	'
Total current assets	134,772	'
Property and equipment, net	21,751	'
Goodwill	82,153	'
Intangible assets, net	9,190	'
Other assets	4,910	'
Total assets	252,776	'
Current liabilities:	'	'
Accounts payable	6,754	'
Accrued expenses	18,094	'
Deferred revenue	7,376	'
Current portion of long-term debt	1,500	'
Other current liabilities	929	'
Total current liabilities	34,653	'
Long-term debt	70,800	'
Deferred tax liabilities	5,440	'
Other long-term liabilities	4,084	'
Stockholders’ equity (deficit):	'	'
Common stock, $0.01 par value: 45,000,000 shares authorized at December 31, 2013 and March 31, 2014; 5,366,478 and 5,545,768 shares issued and outstanding at December 31, 2013 and March 31, 2014, respectively; 30,091,942 shares issued and outstanding at March 31, 2014, pro forma	301	'
Treasury stock	-55	'
Additional paid-in capital	277,085	'
Accumulated deficit	-139,532	'
Total stockholders’ equity (deficit)	137,799	'
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$252,776	'

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Allowance for doubtful accounts (in Dollars)	$642	$530
Preferred stock, par value (in Dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	27,204,144	27,204,144
Preferred stock, shares issued	26,820,270	26,820,270
Preferred stock, shares outstanding	26,820,270	26,820,270
Preferred stock, aggregate liquidation value (in Dollars)	114,627	'
Common stock, par value (in Dollars per share)	$0.01	$0.01
Common stock, shares issued	5,545,768	5,366,478
Common stock, shares outstanding	5,545,768	5,366,478
Common stock, shares authorized	45,000,000	45,000,000
Pro Forma [Member]	'	'
Allowance for doubtful accounts (in Dollars)	$642	'
Preferred stock, par value (in Dollars per share)	$0.01	'
Preferred stock, shares issued	0	'
Preferred stock, shares outstanding	0	'
Common stock, par value (in Dollars per share)	$0.01	'
Common stock, shares issued	30,091,942	'
Common stock, shares outstanding	30,091,942	'

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenues:	'	'
Advertising and sponsorship revenues	$32,692,000	$25,380,000
Premium services revenues	4,813,000	5,124,000
Total revenues	37,505,000	30,504,000
Operating expenses:	'	'
Cost of revenues	11,421,000	9,835,000
Sales and marketing	10,970,000	9,061,000
Product development	10,196,000	10,344,000
General and administrative	6,411,000	6,355,000
Total operating expenses	38,998,000	35,595,000
Loss from operations	-1,493,000	-5,091,000
Interest expense, net	-1,863,000	-2,129,000
Other expense	-4,114,000	'
Loss from continuing operations before provision for income taxes	-7,470,000	-7,220,000
Provision for income taxes	-289,000	-264,000
Loss from continuing operations	-7,759,000	-7,484,000
Loss from discontinued operations, net of tax	'	-1,745,000
Net loss	-7,759,000	-9,229,000
Net loss from continuing operations per common share—basic and diluted (in Dollars per share)	($1.44)	($1.52)
Net loss from discontinued operations per common share—basic and diluted (in Dollars per share)	'	($0.35)
Net loss per common share—basic and diluted (in Dollars per share)	($1.44)	($1.87)
Weighted-average common shares outstanding—basic and diluted (in Shares)	5,403,846	4,925,306
Pro forma net loss per share attributable to common stockholders—basic and diluted	-0.53	'
Pro forma weighted-average common shares outstanding—basic and diluted	$29,950,020	'

Consolidated_Statements_of_Red

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit (USD $)	Redeemable Convertible Preferred Stock [Member]	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
In Thousands, except Share data
Balance at Dec. 31, 2012	$158,766	$49	'	$26,759	($105,458)	($78,650)
Balance (in Shares) at Dec. 31, 2012	26,820,270	4,860,855	'	'	'	'
Exercise of stock options	'	'	'	3	'	3
Exercise of stock options (in Shares)	'	1,666	'	'	'	'
Issuance of common stock	'	1	'	980	'	981
Issuance of common stock (in Shares)	'	108,047	'	'	'	'
Purchase of treasury stock	'	'	-55	'	'	-55
Purchase of treasury stock (in Shares)	'	-7,900	'	'	'	'
Stock-based compensation expense related to stock options	'	'	'	480	'	480
Net loss	'	'	'	'	-9,229	-9,229
Balance at Mar. 31, 2013	158,766	50	-55	28,222	-114,687	-86,470
Balance (in Shares) at Mar. 31, 2013	26,820,270	4,962,668	'	'	'	'
Balance at Dec. 31, 2013	158,766	54	-55	33,726	-123,694	-89,969
Balance (in Shares) at Dec. 31, 2013	26,820,270	5,366,478	'	'	'	'
Exercise of stock options	'	1	'	482	'	483
Exercise of stock options (in Shares)	'	113,580	'	'	'	113,580
Issuance of common stock	'	1	'	918	'	919
Issuance of common stock (in Shares)	'	65,710	'	'	'	5,545,768
Stock-based compensation expense related to stock options	'	'	'	1,069	'	1,069
Warrant issued in connection with website partner agreement	'	'	'	1,131	'	1,131
Net loss	'	'	'	'	-7,759	-7,759
Balance at Mar. 31, 2014	$158,766	$56	($55)	$37,326	($131,453)	($94,126)
Balance (in Shares) at Mar. 31, 2014	26,820,270	5,545,768	'	'	'	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities	'	'
Net loss	($7,759)	($9,229)
Less loss from discontinued operations, net of tax	'	-1,745
Loss from continuing operations	-7,759	-7,484
Adjustments to reconcile loss from continuing operations to net cash provided by operating activities:	'	'
Depreciation and amortization	3,558	3,920
Amortization of video and television costs	'	264
Provision for doubtful accounts	215	62
Stock-based compensation	1,069	452
Amortization and write-off of financing costs	4,169	421
Provision for deferred income taxes	241	241
Changes in operating assets and liabilities:	'	'
Accounts receivable	10,935	7,682
Prepaid expenses and other current assets	-2,645	-420
Additions to video and television costs	'	-389
Accounts payable and accrued expenses	-8,610	-2,398
Deferred revenue	568	1,392
Other current liabilities	32	-352
Other long-term liabilities	307	127
Net cash provided by operating activities from continuing operations	2,080	3,518
Net cash used in operating activities from discontinued operations	'	-1,745
Net cash provided by operating activities	2,080	1,773
Cash flows from investing activities	'	'
Additions to property and equipment, net	-3,476	-2,825
Proceeds from sale of business	152	'
Payment for business purchased, net of cash acquired	'	-2,103
Payment of security deposits and other assets	5	-782
Net cash used in investing activities	-3,319	-5,710
Cash flows from financing activities	'	'
Proceeds from the exercise of stock options	1,172	3
Principal payments on capital lease obligations	-145	-72
Payments of credit facility financing costs	-2,227	'
Payment for purchase of treasury stock	'	-55
Net cash used in financing activities	-233	-832
Net decrease in cash and cash equivalents	-1,472	-4,769
Cash and cash equivalents, beginning of period	16,242	23,888
Cash and cash equivalents, end of period	14,770	19,119
Supplemental disclosure of cash flow information	'	'
Interest paid	2,262	1,670
Income taxes paid	16	'
Supplemental disclosure of non-cash investing and financing activities	'	'
Warrants issued in connection with website partner agreement	1,131	'
Capital lease obligations incurred	193	64
Equity Issued in Business Combination [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities	'	'
Issuance of common stock for acquired business	919	907
Acquired Assets [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities	'	'
Issuance of common stock for acquired assets	'	74
Revolving Credit Facility [Member]	'	'
Cash flows from financing activities	'	'
Repayments of principal	-30,000	'
Borrowings	32,300	'
Payments of credit facility financing costs	1,211	'
Term Loan Facility [Member]	'	'
Cash flows from financing activities	'	'
Repayments of principal	-41,333	-708
Borrowings	$40,000	'

Business

Business	3 Months Ended
	Mar. 31, 2014
Disclosure Text Block [Abstract]	'
Business Description and Basis of Presentation [Text Block]	'
	1. Business
	Everyday Health, Inc. (the “Company”) operates a portfolio of health and wellness websites and mobile applications that provides consumers, healthcare professionals, advertisers and partners with content and advertising-based services. The Company was incorporated in the State of Delaware in January 2002 as Agora Media Inc., and changed its name to Waterfront Media Inc. in January 2004. In January 2010, the Company changed its name to Everyday Health, Inc. to better align its corporate identity with the Everyday Health brand.

Significant_Accounting_Policie

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	2. Significant Accounting Policies
	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.
	Interim Financial Statements
	The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2013 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the three month periods ended March 31, 2013 and 2014. The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s prospectus dated March 27, 2014, filed with the SEC on March 28, 2014 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the “Securities Act”).
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.
	Reclassifications
	Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2014 presentation.
	Initial Public Offering and Pro Forma Presentation
	On April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $72,019, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling approximately $8,325. As a result of the IPO, the Company’s common stock, redeemable convertible preferred stock, additional paid-in capital, and stock options and warrants to purchase stock changed as follows (collectively, the “IPO-Related Transactions”): i) the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, ii) all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision (refer to Note 6), iii) certain selling stockholders exercised stock options and warrants for an aggregate of 262,686 shares of common stock, iv) 149,839 shares of common stock were issued upon the automatic net exercise of a warrant, and v) outstanding warrants to purchase 222,977 shares of redeemable convertible preferred stock automatically converted into warrants to purchase an aggregate of 148,650 shares of common stock, which resulted in the reclassification of the preferred stock warrant liability of $1,140 to additional paid-in capital. The unaudited pro forma March 31, 2014 consolidated balance sheet has been adjusted to reflect the above described IPO-Related Transactions.
	The unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders for the three months ended March 31, 2014 has been adjusted to reflect, as of January 1, 2014, the completion of the Company’s IPO and related changes in stockholders’ equity as described above, and a deemed dividend on Series G redeemable convertible preferred stock of $8,079 (refer to Notes 6 and 8).
	The Company believes that the unaudited pro forma consolidated balance sheet, unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders provides material information to investors, as the historical reported amounts as of and for the three months ended March 31, 2014 were significantly impacted by the closing of the IPO in April 2014. Therefore, the disclosure of the unaudited pro forma consolidated balance sheet, unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders provides measures of equity, net loss and net loss per common share that are comparable to what will be reported by the Company in its consolidated financial statements for the periods subsequent to and including April 2014.
	Revenue Recognition and Deferred Revenue
	The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees.
	Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price.
	Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract.
	Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.
	Cost of Revenues
	Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services.
	Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base.
	Other Expense
	During the three months ended March 31, 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016 in connection with the refinancing of its credit facilities, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations. There were no similar write-offs or charges for the three months ended March 31, 2013.
	Comprehensive Income
	The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented.
	Fair Value of Financial Instruments
	Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in U.S. Treasury securities money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.
	Property and Equipment
	Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement.
	The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.
	The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.
	The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended 2013 and 2014.
	Segment Information
	The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources.
	Recent Accounting Standards
	In April 2014, the Financial Accounting Standards Board issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This will be effective for the first annual reporting period beginning after December 15, 2015, with early adoption permitted. The Company is currently assessing the impact, if any, the guidance with have upon adoption.

Discontinued_Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	'
	3. Discontinued Operations
	In November 2013, the Company completed the sale of its Doctor Solutions business, which provided online directories and other marketing services to healthcare professionals. The sales price was $1,000. The sale represented a disposal of a component of an entity whose operations and cash flows were eliminated from the Company’s ongoing business after the sale. As such, the operating results have been reported as discontinued operations in the consolidated statements of operations for the three months ended March 31, 2013. As the sale was completed during 2013, there were no results from discontinued operations to report for the three months ended March 31, 2014. Revenues and losses from discontinued operations before tax were $2,202 and $1,745, respectively, for the three months ended March 31, 2013. No benefit for income taxes was provided as the Company recorded a full valuation allowance against the net operating losses (“NOLs”) generated by the discontinued operations.

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets Disclosure [Text Block]	'
	4. Goodwill and Other Intangible Assets
	The carrying value of the Company’s goodwill was $82,153 as of March 31, 2014. Goodwill is tested for impairment on an annual basis as of October 1, and whenever events or circumstances indicate that the carrying value of the asset may not be recoverable. Application of the impairment test requires judgment and results in impairment being recognized if the carrying value of the asset exceeds its fair value. No indicators of impairment were noted during or since the Company’s last evaluation of goodwill at October 1, 2013. Similarly, the Company’s definite-lived intangible assets with a net carrying value of $9,190 at March 31, 2014, consisting principally of trade names, customer relationships and agreements with certain of the Company’s website partners, is reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s definite-lived intangible assets during the three months ended 2013 and 2014.
	Definite-lived intangible assets consist of the following:
			31-Dec-13									31-Mar-14
			Gross		Accumulated			Net		Weighted-		Gross		Accumulated			Net carrying amount		Weighted-
			carrying		amortization			carrying		average		carrying		amortization					average
			amount					amount		remaining		amount							remaining
										useful									useful
										life(1)									life(1)
	Customer relationships		$	11,910	$	(10,481	)	$	1,429		2.9	$	11,910	$	(10,624	)	$	1,286		2.7
	Other intangibles			3,900		(2,925	)		975		1.7		3,900		(3,064	)		836		1.5
	Trade names			10,505		(3,174	)		7,331		7		10,505		(3,437	)		7,068		6.7
	Total		$	26,315	$	(16,580	)	$	9,735			$	26,315	$	(17,125	)	$	9,190
	-1	The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.
	Amortization expense relating to the definite-lived intangible assets totaled $1,015 and $545 for the three months ended March 31, 2013 and 2014, respectively, and is included in general and administrative expense in the accompanying consolidated statements of operations.
	Future amortization expense of the intangible assets is estimated to be as follows:
	Year ending December 31:
	2014 (April 1st to December 31st)		$	1,636
	2015			1,938
	2016			1,248
	2017			1,239
	2018			1,051
	Thereafter			2,078
	Total		$	9,190

LongTerm_Debt

Long-Term Debt	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	5. Long-Term Debt
	On March 6, 2014, the Company completed a refinancing of its credit facilities. Under the terms of the new credit facility agreement with a syndicated bank group, the Company maintains a revolver (“Revolver”) with a maximum borrowing limit of $35,000 and a term loan (“Term Loan”) of $40,000. The repayment terms of the Revolver provide for quarterly interest payments, with the principal being due in full in March 2019. The repayment terms of the Term Loan provide for quarterly interest and principal payments, with a maturity date of March 2019. The interest rate on the new credit facility (hereinafter the “Credit Facility”) is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company’s consolidated leverage ratio, as defined in the Credit Facility agreement. As of March 31, 2014, the interest rate on the Credit Facility was 4.23%. The Company drew the full $40,000 Term Loan and $32,300 on the Revolver at closing, and such amounts were outstanding as of March 31, 2014. See Note 11 for discussion of the Revolver pay-down in April 2014.
	During the three months ended March 31, 2014, the Company incurred financing costs on the Credit Facility of $1,211, which have been deferred and are being amortized using the effective interest rate method through the final maturity of the Credit Facility, and incurred prepayment fees of $1,016 on the former credit facilities, which was charged to expense. Deferred financing costs are recorded in other assets in the accompanying consolidated balance sheets. In connection with the refinancing, during the three months ended March 31, 2014, the Company wrote-off unamortized deferred financing costs of $2,845 related to the former credit facilities.
	The Credit Facility contains certain financial and operational covenants, including requirements to maintain a minimum consolidated fixed charge coverage ratio and a maximum consolidated leverage ratio, each as defined in the Credit Facility agreement, as well as restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and the Company’s ability to pay dividends. The Credit Facility is secured by a first priority security interest in substantially all of the Company’s existing and future assets. The Company was in compliance with the financial and operational covenants of the Credit Facility as of March 31, 2014.
	In connection with the refinancing discussed above, the Company repaid all outstanding borrowings under its former credit facilities, and such credit facilities were terminated.
	Under the former senior credit facility, as amended, with a bank, the Company maintained (i) an accounts receivable-backed revolver, with a maximum borrowing limit equal to the lesser of $30,000 and 80% of eligible accounts receivable, and (ii) an $8,500 term loan. As of December 31, 2013, outstanding borrowings under the former revolver and former term loan amounted to $30,000 and $1,333, respectively, and as of such date, the interest rates on the former revolver and former term loan were 5.25% and 6.50%, respectively. The principal under the former revolver was due in full in September 2015. The maturity date of the former term loan was December 2014.
	Under the Company’s former subordinated credit facility, as amended, the Company maintained a $40,000 term loan. As of December 31, 2013, outstanding borrowings under the former subordinated credit facility amounted to $40,000 and the interest rate on such facility was 14.0%. The maturity date of the former subordinated credit facility was October 2015 with respect to $35,000 and November 2016 with respect to $5,000.
	The former senior credit facility and former subordinated credit facility contained certain financial and operational covenants, including restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and the ability of the Company to pay dividends and make other distributions. The Company was in compliance with the financial and operational covenants of the former credit facility and former subordinated credit facility as of December 31, 2013.
	In connection with the former senior credit facility and former subordinated credit facility, as well as other former credit facilities that were in place previously, the Company issued to the lenders warrants to purchase a total of: i) 592,501 shares of common stock at $0.015 per share, ii) 112,959 shares of Series F redeemable convertible preferred stock at $7.61 per share, and (iii) 110,018 shares of Series C redeemable convertible preferred stock at $3.27 per share. Each of the above warrants were immediately exercisable and, accordingly, the Company calculated the fair value of the warrants using the Black-Scholes option pricing model and recorded deferred financing costs related to the issuances of the warrants in the respective periods.
	On April 2, 2014, in connection with the closing of the Company’s IPO, the above warrants to purchase 222,977 shares of preferred stock were converted into warrants to purchase an aggregate of 148,650 shares of common stock. This conversion resulted in the warrant liability of $1,140 being reclassified to additional paid-in capital as of April 2, 2014.

Common_Stock_and_Redeemable_Co

Common Stock and Redeemable Convertible Preferred Stock	3 Months Ended
	Mar. 31, 2014
Share-based Arrangements with Employees and Nonemployees [Abstract]	'
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	'
	6. Common Stock and Redeemable Convertible Preferred Stock
	On March 12, 2014, the Company’s Board of Directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company’s issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company’s consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.
	The number of shares of the Company’s redeemable convertible preferred stock was not adjusted in connection with the 1-for-1.5 reverse stock split of common stock referred to above. The Company’s redeemable convertible preferred stock consisted of the following at each of December 31, 2013 and March 31, 2014:
		Shares				Stated value,
		Authorized		Issued and		net of		Liquidation
				outstanding		expenses		preference
	Redeemable convertible preferred stock:
	Series A		3,450,000		3,450,000	$	1,053	$	1,725
	Series B		2,547,252		2,547,252		4,413		4,500
	Series C		1,943,651		1,833,633		5,882		6,000
	Series D		3,934,855		3,934,855		25,354		27,027
	Series E		8,930,966		8,930,966		71,250		15,789
	Series F		3,064,087		2,951,128		22,468		22,468
	Series G		3,333,333		3,172,436		28,346		37,118
	Total		27,204,144		26,820,270	$	158,766	$	114,627
	Conversion of the Redeemable Convertible Preferred Stock
	Each share of redeemable convertible preferred stock was convertible at the option of the holder, at any time, into such number of fully paid shares of the Company’s common stock equal to the applicable original issue price for such share of redeemable convertible preferred stock divided by the applicable conversion price for such share of redeemable convertible preferred stock then in effect. As of December 31, 2013, the original issue prices and the conversion prices for each series of redeemable convertible preferred stock were as follows: $0.50 for Series A, $1.77 for Series B, $3.27 for Series C, $6.87 for Series D, $7.98 for Series E, $7.61 for Series F and $9.00 for Series G. The conversion prices for each series of redeemable convertible preferred stock were subject to adjustment upon the occurrence of certain specified events, including stock dividends, stock splits, combinations or other similar recapitalizations, and issuance of capital stock at a price below the conversion price in effect for such series of redeemable convertible preferred stock. The conversion price for the Series G convertible preferred stock was also subject to further adjustment in the event of an IPO with a public offering price of less than $11.88 per share.
	In connection with the March 14, 2014 1-for-1.5 reverse stock split, the conversion prices for each series of redeemable convertible preferred stock were subject to a 1-for-1.5 adjustment. As a result, upon the closing of the IPO, the 23,647,834 outstanding shares of Series A, Series B, Series C, Series D, Series E and Series F redeemable convertible preferred stock converted into a total of 15,765,223 shares of common stock. Based on this 1-for-1.5 adjustment, the conversion price for the IPO adjustment specific to the Series G shares increased from $11.88 per share to $17.82 per share. Based on the public offering price of $14.00 per share, the 3,172,436 outstanding shares of Series G convertible preferred stock converted into a total of 2,692,012 shares of common stock, including an additional 577,055 shares of common stock issued as a result of the specific Series G IPO adjustment feature or “ratchet provision.” The ratchet provision, which is treated as a deemed stock dividend for accounting purposes, was calculated as the difference between the number of shares of common stock each holder of Series G would receive upon the automatic conversion of the Series G shares and the number of shares contingently issuable just prior to the automatic conversion based on the initial conversion price multiplied by the IPO price of $14.00 per share, which represents the fair value of the common stock on the date of conversion. On April 2, 2014, the Company recorded a one-time $8,079 non-cash preferred stock deemed dividend related to the issuance of additional common shares resulting from the ratchet provision. Such non-cash preferred stock deemed dividend results in an increase to net loss to arrive at net loss attributable to common stockholders and, consequently, results in an adjustment to the Company’s computation of net loss per share attributable to common stockholders (refer to Note 8).
	Issuance of Common Stock Warrant
	During the three months ended March 31, 2014, the Company issued to one of its website partners a warrant to purchase 100,000 shares of common stock at $0.015 per share, in connection with the website partner agreeing to extend the advertising representation agreement by two years. The warrant was immediately exercisable and, accordingly, the Company calculated the fair value of the warrant using the Black-Scholes option pricing model and recorded $1,131 of deferred financing costs related to the issuance, which will be amortized to the Company’s operating results over the remaining life of the agreement.

StockBased_Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	7. Stock-Based Compensation
	Stock Options
	The Company has historically granted non-statutory stock options to employees, directors and consultants of the Company pursuant to its 2003 Stock Option Plan, as amended (the “2003 Plan”). The Board of Directors and the Company’s stockholders subsequently approved the 2014 Equity Incentive Plan (the “2014 Plan”), which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014. Upon the effectiveness of the 2014 Plan, no additional options have been or will be granted under the 2003 Plan.
	The aggregate number of shares of the Company’s common stock that may be issued pursuant to the 2014 Plan is the sum of (1) 200,000 shares, (2) the 388,781 shares reserved for issuance under the 2003 Plan at the time the 2014 Plan became effective, and (3) any shares subject to outstanding stock options that would otherwise have returned to the 2003 Plan (such as upon the expiration or termination of stock options prior to vesting). In addition, the number of shares of common stock reserved for issuance under the 2014 Plan will automatically increase on January 1 of each year from January 1, 2015 through January 1, 2024 by the lesser of (a) 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors. As of March 31, 2014, 593,574 shares have been reserved for issuance under the 2014 Plan and no shares have been granted under the 2014 Plan.
	The following table summarizes stock option activity for the three months ended March 31, 2014:
		Number of			Weighted-			Weighted-		Aggregate
		options			average			average		intrinsic
					exercise			remaining		value
					price			contractual
								life (years)
	Outstanding at December 31, 2013		5,457,791		$	7.61			6.54		20,396
	Granted		1,472,101			14.53
	Exercised		(113,580	)		4.26
	Cancelled		(142,506	)		8.22
	Outstanding at March 31, 2014		6,673,806		$	9.14			7.12	$	33,737
	Exercisable at March 31, 2014		3,965,974		$	7.33			5.59	$	26,396
	Proceeds from the exercise of options and the total intrinsic value of the options exercised were $1,172 and $910, respectively, for the three months ended March 31, 2014. Proceeds from the exercise of options and the total intrinsic value of the options exercised were $3 and $12, respectively, for the three months ended March 31, 2013.
	There were no options granted during the three months ended March 31, 2013. The weighted-average fair value per share at date of grant for options granted during the three months ended March 31, 2014 was $7.56. The fair value of options granted is estimated on the date of grant using the Black-Scholes option pricing model and recognized in expense over the vesting period of the options using the graded attribution method.
	The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the three months ended March 31, 2013 and 2014:
			2013			2014
	Volatility		50.26	%		49.77	%
	Expected life (years)		6.25			6.25
	Risk-free interest rate		1.32	%		1.92	%
	Dividend yield		—			—
	The expected stock price volatilities are estimated based on historical realized volatilities of comparable publicly traded company stock prices over a period of time commensurate with the expected term of the option award. The expected life represents the period of time for which the options granted are expected to be outstanding. The Company used the simplified method for determining expected life for options qualifying for treatment due to the limited history the Company currently has with option exercise activity. The risk-free interest rate is based on the U.S. Treasury yield curve for periods equal to the expected term of the options on the grant date.
	Total stock-based compensation expense was $480 (including $28 relating to discontinued operations) and $1,069 for the three months ended March 31, 2013 and 2014, respectively.
	At March 31, 2014, there was approximately $11,755 of unrecognized compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 2.98 years. The total fair value of stock options vested during the three months ended March 31, 2013 and 2014 was $1,402 and $953, respectively.
	2014 Employee Stock Purchase Plan
	The Company’s directors adopted, and the stockholders subsequently approved, the 2014 Employee Stock Purchase Plan (“ESPP”). The ESPP, which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014, authorizes the issuance of 500,000 shares of the Company’s common stock pursuant to purchase rights granted to employees. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b). Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase. For the initial offering period, the fair market value on the first day of the offering period was the $14.00 IPO price. Generally, all regular employees may participate in the ESPP and may contribute, through payroll deductions, up to 15% of their earnings toward the purchase of common stock under the ESPP. Under the terms of the ESPP, there are defined limitations as to the amount and value of common stock that can be purchased by each employee. The ESPP did not materially impact the Company’s results of operations for the three months ended March 31, 2014.

Net_Loss_Per_Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	8. Net Loss Per Share
	Basic net loss per share is computed by dividing net loss by the weighted-average number of outstanding shares of common stock during the period. Diluted net loss per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential common shares outstanding during the period. Potential common shares include incremental shares issuable upon the assumed exercise of stock options and warrants using the treasury stock method. For the three months ended March 31, 2013 and 2014, the Company had outstanding options, warrants and preferred stock as disclosed in Notes 5, 6 and 7, which were convertible into or exercisable for common shares that were not included in the calculation of diluted loss per common share because the effect would have been anti-dilutive.
	The unaudited pro forma net loss per share attributable to common stockholders for the three months ended March 31, 2014 assumes as of the first day of the quarter then ended (i) the conversion of all outstanding shares of redeemable convertible preferred stock into an aggregate of 18,457,235 shares of common stock, (ii) the issuance of 149,839 shares of common stock upon the automatic net exercise of a warrant, (iii) the issuance and sale of 5,622,686 common shares, including 262,686 from exercises of stock options and warrants by selling stockholders, upon the closing of the IPO, and (iv) the issuance and sale of 316,414 common shares pursuant to the underwriters’ exercise of their over-allotment option. Additionally, the pro forma net loss per share attributable to common stockholders reflects a deemed dividend on Series G redeemable convertible preferred stock of $8,079 resulting from the Series G ratchet provision (refer to Note 6).
		Three months ended March 31,
		2014
	Numerator:
	Historical net loss		$	(7,759	)
	Plus: deemed dividend on Series G Preferred Stock			(8,079	)
	Pro forma numerator for basic and diluted net loss per share attributable to common stockholders		$	(15,838	)
	Denominator:
	Historical denominator for basic and diluted net loss per share—weighted average shares			5,403,846
	Plus: conversion of redeemable convertible preferred stock to common stock			18,457,235
	Plus: automatic net exercise of a warrant			149,839
	Plus: shares issued upon initial public offering, including shares exercised by certain selling shareholders			5,622,686
	Plus: shares issued pursuant to the underwriters’ exercise of their over-allotment option			316,414
	Pro forma denominator for basic and diluted net loss per share attributable to common shareholders			29,950,020
	Pro forma basic and diluted net loss per share attributable to common shareholders		$	(0.53	)

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	9. Income Taxes
	The Company’s interim and annual tax provision is primarily comprised of a deferred tax provision pertaining to basis differences in indefinite lived intangible assets that cannot be offset by current year deferred tax assets, as well as, to a much lesser extent, a current tax provision for state, local and foreign taxes. Based on seasonality, the Company has historically experienced pretax losses in certain quarters and pretax income in others. Due to the combination of these items, the Company believes that using an annual effective tax rate would result in significant variances in the customary relationship between income tax expense and pretax income or loss in interim periods. As a result, the tax provision in interim periods is based upon the estimated deferred and current tax provision for the year rather than the estimated annual effective tax rate.
	At December 31, 2013, the Company had approximately $108,000 of NOL carryforwards available to offset future taxable income, which expire from 2020 through 2033. The full utilization of these losses in the future is dependent upon the Company’s ability to generate taxable income and may also be limited due to ownership changes, as defined under the provisions of Section 382 of the Internal Revenue Code of 1986, as amended. The Company’s NOL carryforwards at December 31, 2013 include $3,317 in income tax deductions related to stock options. The benefit of these losses will be reflected as a credit to additional paid-in capital as realized.
	The Company has provided a valuation allowance against deferred tax assets to the extent the Company has determined that it is more likely than not that such net deferred tax assets will not be realizable. In determining realizability, the Company considered various factors including historical profitability and reversing temporary differences. The Company’s net deferred tax liabilities arose due primarily to basis differences in indefinite-lived intangible assets that cannot be offset by current year deferred tax assets.
	The Company is subject to taxation in the U.S. and various state, local and foreign jurisdictions. In February 2014, the Company received notification that its U.S. Federal tax return for the year ended December 31, 2011 would be audited. As of March 31, 2014, none of the Company’s other tax returns have been examined by any income taxing authority. The Company is not subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years prior to 2010. However, to the extent U.S. federal and state NOL carryforwards are utilized, the use of NOLs could be subject to examination by the tax authorities. The Company believes that it has appropriate support for the income tax positions taken and to be taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on assessment of many factors, including past experience and interpretations of tax law. The Company regularly assesses the adequacy of its income tax contingencies in accordance with ASC 740. As a result, the Company may adjust its income tax contingency liabilities for the impact of new facts and developments, such as changes in interpretations of relevant tax law and assessments from taxing authorities.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	10. Commitments and Contingencies
	The Company is subject to certain claims that have arisen in the ordinary conduct of business. Based on the advice of counsel and an assessment of the nature and status of any potential claim, and taking into account any accruals the Company may have established for them, the Company currently believes that any liabilities ultimately resulting from such claims will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	11. Subsequent Events
	On April 2, 2014, the Company closed its IPO. The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $72,019, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling approximately $8,325. As a result of the IPO, the Company’s common stock, redeemable convertible preferred stock, additional paid-in capital, and stock options and warrants to purchase stock changed as follows: i) the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, ii) all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision (refer to Note 6), iii) certain selling stockholders exercised stock options and warrants for an aggregate of 262,686 shares of common stock, iv) 149,839 shares of common stock were issued upon the automatic net exercise of a warrant, and v) outstanding warrants to purchase 222,977 shares of redeemable convertible preferred stock automatically converted into warrants to purchase an aggregate of 148,650 shares of common stock, which resulted in the reclassification of the preferred stock warrant liability of $1,140 to additional paid-in capital.
	On April 2, 2014, in connection with the closing of the Company’s IPO, the Company filed an amended and restated certificate of incorporation with the Secretary of State of the State of Delaware that amended and restated in its entirety the Company’s certificate of incorporation to, among other things, increase the total number of shares of the Company’s common stock that the Company is authorized to issue to 90,000,000, eliminate all references to the various series of preferred stock that were previously authorized (including certain protective measures held by the various series of preferred stock), and to authorize up to 10,000,000 shares of undesignated preferred stock that may be issued, from time to time with terms to be set, by the Company’s Board of Directors, which rights could be senior to those of the Company’s common stock.
	On April 7, 2014, the Company paid down the $32,300 outstanding balance on its Revolver. As of the date of this filing, the full $35,000 line under the Revolver was available to be drawn (see Note 5).

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Consolidation, Policy [Policy Text Block]	'
	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation
Interim Financial Statement [Policy Text Block]	'
	Interim Financial Statements
	The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2013 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the three month periods ended March 31, 2013 and 2014. The results of operations for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s prospectus dated March 27, 2014, filed with the SEC on March 28, 2014 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the “Securities Act”).
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.
Reclassification, Policy [Policy Text Block]	'
	Reclassifications
	Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2014 presentation.
Sale of Stock, Description of Transaction	'Initial Public Offering and Pro Forma PresentationOn April 2, 2014, the Company closed its initial public offering of common stock ("IPO"). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters' exercise of their over-allotment option, resulted in net proceeds of $72,019, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling approximately $8,325. As a result of the IPO, the Company's common stock, redeemable convertible preferred stock, additional paid-in capital, and stock options and warrants to purchase stock changed as follows (collectively, the "IPO-Related Transactions"): i) the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, ii) all of the Company's redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision (refer to Note 6), iii) certain selling stockholders exercised stock options and warrants for an aggregate of 262,686 shares of common stock, iv) 149,839 shares of common stock were issued upon the automatic net exercise of a warrant, and v) outstanding warrants to purchase 222,977 shares of redeemable convertible preferred stock automatically converted into warrants to purchase an aggregate of 148,650 shares of common stock, which resulted in the reclassification of the preferred stock warrant liability of $1,140 to additional paid-in capital. The unaudited pro forma March 31, 2014 consolidated balance sheet has been adjusted to reflect the above described IPO-Related Transactions.The unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders for the three months ended March 31, 2014 has been adjusted to reflect, as of January 1, 2014, the completion of the Company's IPO and related changes in stockholders' equity as described above, and a deemed dividend on Series G redeemable convertible preferred stock of $8,079 (refer to Notes 6 and 8).The Company believes that the unaudited pro forma consolidated balance sheet, unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders provides material information to investors, as the historical reported amounts as of and for the three months ended March 31, 2014 were significantly impacted by the closing of the IPO in April 2014. Therefore, the disclosure of the unaudited pro forma consolidated balance sheet, unaudited pro forma net loss attributable to common stockholders and unaudited pro forma net loss per share attributable to common stockholders provides measures of equity, net loss and net loss per common share that are comparable to what will be reported by the Company in its consolidated financial statements for the periods subsequent to and including April 2014.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition and Deferred Revenue
	The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees.
	Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price.
	Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract.
	Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.
Cost of Sales, Policy [Policy Text Block]	'
	Cost of Revenues
	Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services.
	Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base.
Other Income and Other Expense Disclosure [Text Block]	'
	Other Expense
	During the three months ended March 31, 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016 in connection with the refinancing of its credit facilities, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations. There were no similar write-offs or charges for the three months ended March 31, 2013.
Comprehensive Income, Policy [Policy Text Block]	'
	Comprehensive Income
	The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	Fair Value of Financial Instruments
	Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in U.S. Treasury securities money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.
Property, Plant and Equipment, Policy [Policy Text Block]	'
	Property and Equipment
	Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement.
	The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.
	The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.
	The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended 2013 and 2014.
Segment Reporting, Policy [Policy Text Block]	'
	Segment Information
	The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recent Accounting Standards
	In April 2014, the Financial Accounting Standards Board issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This will be effective for the first annual reporting period beginning after December 15, 2015, with early adoption permitted. The Company is currently assessing the impact, if any, the guidance with have upon adoption

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Intangible Assets Disclosure [Text Block]	'Definite-lived intangible assets consist of the following:
			31-Dec-13									31-Mar-14
			Gross		Accumulated			Net		Weighted-		Gross		Accumulated			Net carrying amount		Weighted-
			carrying		amortization			carrying		average		carrying		amortization					average
			amount					amount		remaining		amount							remaining
										useful									useful
										life(1)									life(1)
	Customer relationships		$	11,910	$	(10,481	)	$	1,429		2.9	$	11,910	$	(10,624	)	$	1,286		2.7
	Other intangibles			3,900		(2,925	)		975		1.7		3,900		(3,064	)		836		1.5
	Trade names			10,505		(3,174	)		7,331		7		10,505		(3,437	)		7,068		6.7
	Total		$	26,315	$	(16,580	)	$	9,735			$	26,315	$	(17,125	)	$	9,190
	-1	The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	'Future amortization expense of the intangible assets is estimated to be as follows:
	Year ending December 31:
	2014 (April 1st to December 31st)		$	1,636
	2015			1,938
	2016			1,248
	2017			1,239
	2018			1,051
	Thereafter			2,078
	Total		$	9,190

Common_Stock_and_Redeemable_Co1

Common Stock and Redeemable Convertible Preferred Stock (Tables)	3 Months Ended
	Mar. 31, 2014
Share-based Arrangements with Employees and Nonemployees [Abstract]	'
Redeemable Noncontrolling Interest [Table Text Block]	'The number of shares of the Company’s redeemable convertible preferred stock was not adjusted in connection with the 1-for-1.5 reverse stock split of common stock referred to above. The Company’s redeemable convertible preferred stock consisted of the following at each of December 31, 2013 and March 31, 2014:
		Shares				Stated value,
		Authorized		Issued and		net of		Liquidation
				outstanding		expenses		preference
	Redeemable convertible preferred stock:
	Series A		3,450,000		3,450,000	$	1,053	$	1,725
	Series B		2,547,252		2,547,252		4,413		4,500
	Series C		1,943,651		1,833,633		5,882		6,000
	Series D		3,934,855		3,934,855		25,354		27,027
	Series E		8,930,966		8,930,966		71,250		15,789
	Series F		3,064,087		2,951,128		22,468		22,468
	Series G		3,333,333		3,172,436		28,346		37,118
	Total		27,204,144		26,820,270	$	158,766	$	114,627

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'The following table summarizes stock option activity for the three months ended March 31, 2014:
		Number of			Weighted-			Weighted-		Aggregate
		options			average			average		intrinsic
					exercise			remaining		value
					price			contractual
								life (years)
	Outstanding at December 31, 2013		5,457,791		$	7.61			6.54		20,396
	Granted		1,472,101			14.53
	Exercised		(113,580	)		4.26
	Cancelled		(142,506	)		8.22
	Outstanding at March 31, 2014		6,673,806		$	9.14			7.12	$	33,737
	Exercisable at March 31, 2014		3,965,974		$	7.33			5.59	$	26,396
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the three months ended March 31, 2013 and 2014:
			2013			2014
	Volatility		50.26	%		49.77	%
	Expected life (years)		6.25			6.25
	Risk-free interest rate		1.32	%		1.92	%
	Dividend yield		—			—

Net_Loss_Per_Share_Tables

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
		Three months ended March 31,
		2014
	Numerator:
	Historical net loss		$	(7,759	)
	Plus: deemed dividend on Series G Preferred Stock			(8,079	)
	Pro forma numerator for basic and diluted net loss per share attributable to common stockholders		$	(15,838	)
	Denominator:
	Historical denominator for basic and diluted net loss per share—weighted average shares			5,403,846
	Plus: conversion of redeemable convertible preferred stock to common stock			18,457,235
	Plus: automatic net exercise of a warrant			149,839
	Plus: shares issued upon initial public offering, including shares exercised by certain selling shareholders			5,622,686
	Plus: shares issued pursuant to the underwriters’ exercise of their over-allotment option			316,414
	Pro forma denominator for basic and diluted net loss per share attributable to common shareholders			29,950,020
	Pro forma basic and diluted net loss per share attributable to common shareholders		$	(0.53	)

Significant_Accounting_Policie1

Significant Accounting Policies (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Apr. 02, 2014	Dec. 31, 2013
Significant Accounting Policies (Details) [Line Items]	'	'	'
Proceeds from Issuance Initial Public Offering	'	$72,019	'
Payments for Underwriting Expense	'	8,325	'
Common Stock, Shares, Issued	5,545,768	5,676,414	5,366,478
Common Stock, No Par Value	'	$14	'
Convertible Preferred Stock, Shares Issued upon Conversion	'	18,457,235	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	113,580	262,686	'
Temporary Equity, Shares Issued	'	149,839	'
Class of Warrant or Right, Outstanding	100,000	222,977	'
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	149,839	148,650	'
Adjustment of Warrants Granted for Services	'	1,140	'
Debtor Reorganization Items, Write-off of Deferred Financing Costs and Debt Discounts	'	2,845	'
Banking Fees and Commissions	'	1,016	'
Capital Units, Adjustment for Market Changes	'	253	'
Number of Reportable Segments	1	'	'
Ratchet Provision Deemed Dividend [Member] | Series G Preferred Stock [Member]	'	'	'
Significant Accounting Policies (Details) [Line Items]	'	'	'
Dividends	8,079	$8,079	'
Series G Preferred Stock [Member]	'	'	'
Significant Accounting Policies (Details) [Line Items]	'	'	'
Convertible Preferred Stock, Shares Issued upon Conversion	'	577,055	'
Minimum [Member]	'	'	'
Significant Accounting Policies (Details) [Line Items]	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'three	'	'
Maximum [Member]	'	'	'
Significant Accounting Policies (Details) [Line Items]	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'five	'	'
Software and Software Development Costs [Member]	'	'	'
Significant Accounting Policies (Details) [Line Items]	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'three	'	'
Website And Mobile Applications [Member]	'	'	'
Significant Accounting Policies (Details) [Line Items]	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'three	'	'

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	1 Months Ended	3 Months Ended
In Thousands, unless otherwise specified	Nov. 30, 2013	Mar. 31, 2014	Mar. 31, 2014
		Revenues [Member]	Losses [Member]
Discontinued Operations (Details) [Line Items]	'	'	'
Proceeds from Sales of Business, Affiliate and Productive Assets	$1,000	'	'
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	'	$2,202	($1,745)

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'	'
Goodwill	$82,153	'	$82,153
Finite-Lived Intangible Assets, Net	9,190	'	9,735
Amortization of Intangible Assets	$545	$1,015	'

Goodwill_and_Other_Intangible_3

Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014		Dec. 31, 2013
Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets [Line Items]	'		'
Gross carrying amount	$26,315		$26,315
Accumulated amortization	-17,125		-16,580
Net carrying amount	9,190		9,735
Customer Relationships [Member]	'		'
Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets [Line Items]	'		'
Gross carrying amount	11,910		11,910
Accumulated amortization	-10,624		-10,481
Net carrying amount	1,286		1,429
Weighted- average remaining useful life	'2 years 255 days	[1]	'2 years 328 days	[1]
Other Intangible Assets [Member]	'		'
Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets [Line Items]	'		'
Gross carrying amount	3,900		3,900
Accumulated amortization	-3,064		-2,925
Net carrying amount	836		975
Weighted- average remaining useful life	'1 year 6 months	[1]	'1 year 255 days	[1]
Trade Names [Member]	'		'
Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets [Line Items]	'		'
Gross carrying amount	10,505		10,505
Accumulated amortization	-3,437		-3,174
Net carrying amount	$7,068		$7,331
Weighted- average remaining useful life	'6 years 255 days	[1]	'7 years	[1]
[1]	The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.

Goodwill_and_Other_Intangible_4

Goodwill and Other Intangible Assets (Details) - Schedule of future amortization expense of intangible assets (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Schedule of future amortization expense of intangible assets [Abstract]	'	'
2014 (April 1st to December 31st)	$1,636	'
2015	1,938	'
2016	1,248	'
2017	1,239	'
2018	1,051	'
Thereafter	2,078	'
Total	$9,190	$9,735

LongTerm_Debt_Details

Long-Term Debt (Details) (USD $)

3 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

3 Months Ended

In Thousands, except Share data, unless otherwise specified

Mar. 31, 2014

Apr. 02, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Apr. 02, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Series F Preferred Stock [Member]

Series C Preferred Stock [Member]

IPO [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Term Loan Facility [Member]

Term Loan Facility [Member]

Former credit facility [Member]

Minimum [Member]

Maximum [Member]

Former credit facility [Member]

Former credit facility [Member]

Long-Term Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

'

'

$35,000

'

$40,000

'

'

'

'

Line of Credit Facility, Interest Rate Description

'The interest rate on the new credit facility (hereinafter the "Credit Facility") is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company's consolidated leverage ratio

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Interest Rate at Period End

4.23%

'

'

'

'

'

'

'

'

'

'

2.75%

4.00%

Line of Credit Facility, Amount Outstanding

'

'

'

'

'

'

32,300

'

40,000

'

'

'

'

Payments of Financing Costs

-2,227

'

'

'

'

'

1,211

'

'

'

1,016

'

'

Write off of Deferred Debt Issuance Cost

'

'

'

'

'

'

'

'

'

'

2,845

'

'

Line of Credit Facility, Borrowing Capacity, Description

'Under the former senior credit facility, as amended, with a bank, the Company maintained (i) an accounts receivable-backed revolver, with a maximum borrowing limit equal to the lesser of $30,000 and 80% of eligible accounts receivable, and (ii) an $8,500 term loan.

'

'

'

'

'

'

'

'

'

'

'

'

Debtor-in-Possession Financing, Borrowings Outstanding

'

'

40,000

'

'

'

'

30,000

'

1,333

'

'

'

Debtor-in-Possession Financing, Interest Rate on Borrowings Outstanding

'

'

14.00%

'

'

'

'

5.25%

'

6.50%

'

'

'

Shares upon warrant exercises (in Shares)

'

'

'

112,959

110,018

'

'

'

'

'

592,501

'

'

Investment Warrants, Exercise Price (in Dollars per share)

$0.02

'

'

$7.61

$3.27

'

'

'

'

'

$0.02

'

'

Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)

'

18,457,235

'

'

'

222,977

'

'

'

'

'

'

'

Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock (in Shares)

'

'

'

'

'

148,650

'

'

'

'

'

'

'

Additional Paid in Capital

$37,326

$1,140

$33,726

'

'

'

'

'

'

'

'

'

'

Common_Stock_and_Redeemable_Co2

Common Stock and Redeemable Convertible Preferred Stock (Details) (USD $)

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

In Thousands, except Share data, unless otherwise specified

Mar. 31, 2014

Apr. 02, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Apr. 02, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Effect of 1-for-1.5 stock split [Member]

Ratchet Provision [Member]

Ratchet Provision Deemed Dividend [Member]

Ratchet Provision Deemed Dividend [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series E Preferred Stock [Member]

Series E Preferred Stock [Member]

Series F Preferred Stock [Member]

Series F Preferred Stock [Member]

Series G Preferred Stock [Member]

Series G Preferred Stock [Member]

Series A, B, C, D, E, F [Member]

Series G Preferred Stock [Member]

Series G Preferred Stock [Member]

Series G Preferred Stock [Member]

Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders' Equity, Reverse Stock Split

'On March 12, 2014, the Company's Board of Directors and stockholders approved an amendment to the Company's amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company's issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company's consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares Issued, Price Per Share

$14

'

'

'

'

'

'

$0.50

'

$1.77

'

$3.27

'

$6.87

'

$7.98

'

$7.61

'

$9

'

Conversion Price IPO Adjustment Threshold

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$11.88

'

'

Temporary Equity, Shares Outstanding (in Shares)

26,820,270

'

'

'

'

'

3,450,000

'

2,547,252

'

1,833,633

'

3,934,855

'

8,930,966

'

2,951,128

'

3,172,436

'

23,647,834

Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,692,012

'

15,765,223

Conversion Price IPO Adjustment Increase

'

'

$17.82

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock (in Shares)

'

'

'

577,055

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividends (in Dollars)

'

'

'

'

$8,079

$8,079

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Outstanding (in Shares)

100,000

222,977

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Investment Warrants, Exercise Price

$0.02

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred Tax Liabilities, Deferred Expense, Deferred Financing Costs (in Dollars)

$1,131

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common_Stock_and_Redeemable_Co3

Common Stock and Redeemable Convertible Preferred Stock (Details) - Schedule of redeemable convertible preferred stock (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Redeemable convertible preferred stock:	'	'
Redeemable convertible preferred stock	27,204,144	27,204,144
Redeemable convertible preferred stock	26,820,270	'
Redeemable convertible preferred stock	$158,766	$158,766
Redeemable convertible preferred stock	114,627	'
Series A Preferred Stock [Member]	'	'
Redeemable convertible preferred stock:	'	'
Redeemable convertible preferred stock	3,450,000	'
Redeemable convertible preferred stock	3,450,000	'
Redeemable convertible preferred stock	1,053	'
Redeemable convertible preferred stock	1,725	'
Series B Preferred Stock [Member]	'	'
Redeemable convertible preferred stock:	'	'
Redeemable convertible preferred stock	2,547,252	'
Redeemable convertible preferred stock	2,547,252	'
Redeemable convertible preferred stock	4,413	'
Redeemable convertible preferred stock	4,500	'
Series C Preferred Stock [Member]	'	'
Redeemable convertible preferred stock:	'	'
Redeemable convertible preferred stock	1,943,651	'
Redeemable convertible preferred stock	1,833,633	'
Redeemable convertible preferred stock	5,882	'
Redeemable convertible preferred stock	6,000	'
Series D Preferred Stock [Member]	'	'
Redeemable convertible preferred stock:	'	'
Redeemable convertible preferred stock	3,934,855	'
Redeemable convertible preferred stock	3,934,855	'
Redeemable convertible preferred stock	25,354	'
Redeemable convertible preferred stock	27,027	'
Series E Preferred Stock [Member]	'	'
Redeemable convertible preferred stock:	'	'
Redeemable convertible preferred stock	8,930,966	'
Redeemable convertible preferred stock	8,930,966	'
Redeemable convertible preferred stock	71,250	'
Redeemable convertible preferred stock	15,789	'
Series F Preferred Stock [Member]	'	'
Redeemable convertible preferred stock:	'	'
Redeemable convertible preferred stock	3,064,087	'
Redeemable convertible preferred stock	2,951,128	'
Redeemable convertible preferred stock	22,468	'
Redeemable convertible preferred stock	22,468	'
Series G Preferred Stock [Member]	'	'
Redeemable convertible preferred stock:	'	'
Redeemable convertible preferred stock	3,333,333	'
Redeemable convertible preferred stock	3,172,436	'
Redeemable convertible preferred stock	28,346	'
Redeemable convertible preferred stock	$37,118	'

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	3 Months Ended			3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 27, 2014
				2014 Plan [Member]	Employee Stock [Member]	Employee Stock [Member]
Stock-Based Compensation (Details) [Line Items]	'	'	'	'	'	'
Common stock, aggregate shares issued, description	'	'	'	'The aggregate number of shares of the Company's common stock that may be issued pursuant to the 2014 Plan is the sum of (1) 200,000 shares, (2) the 388,781 shares reserved for issuance under the 2003 Plan at the time the 2014 Plan became effective, and (3) any shares subject to outstanding stock options that would otherwise have returned to the 2003 Plan (such as upon the expiration or termination of stock options prior to vesting).	'	'
Common stock, number of shares reserved for issuance, description	'	'	'	'In addition, the number of shares of common stock reserved for issuance under the 2014 Plan will automatically increase on January 1 of each year from January 1, 2015 through January 1, 2024 by the lesser of (a) 4% of the total number of shares of the Company's common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors.	'The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b).	'
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)	'	'	'	593,574	'	'
Proceeds from Stock Options Exercised	$1,172,000	$3,000	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	910,000	12,000	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$7.56	'	'	'	'	'
Allocated Share-based Compensation Expense	'	480,000	'	'	'	'
Other Adjustments to Income, Discontinued Operations	'	28	'	'	'	'
Share-based Compensation	1,069,000	452,000	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	11,755,000	'	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	'2 years 357 days	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$953,000	$1,402,000	'	'	'	'
Common Stock, Shares Authorized (in Shares)	45,000,000	'	45,000,000	'	'	500,000
Common stock, purchase for participating employee price, description	'	'	'	'	'Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase.	'
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$0.01	'	$0.01	'	$14	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares)	'	'	'	'	0.15	'

StockBased_Compensation_Detail1

Stock-Based Compensation (Details) - Schedule of stock option activity (USD $)	0 Months Ended	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2014	Apr. 02, 2014
Schedule of stock option activity [Abstract]	'	'	'
Outstanding	5,457,791	6,673,806	'
Outstanding	$7.61	$9.14	'
Outstanding	'6 years 197 days	'7 years 43 days	'
Outstanding	$20,396	$33,737	'
Granted	'	1,472,101	'
Granted	'	$14.53	'
Exercised	'	-113,580	-262,686
Exercised	'	$4.26	'
Cancelled	'	-142,506	'
Cancelled	'	$8.22	'
Exercisable at March 31, 2014	'	3,965,974	'
Exercisable at March 31, 2014	'	$7.33	'
Exercisable at March 31, 2014	'	'5 years 215 days	'
Exercisable at March 31, 2014	'	$26,396	'

StockBased_Compensation_Detail2

Stock-Based Compensation (Details) - Schedule of weighted-average assumptions (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Schedule of weighted-average assumptions [Abstract]	'	'
Volatility	49.77%	50.26%
Expected life (years)	'6 years 3 months	'6 years 3 months
Risk-free interest rate	1.92%	1.32%
Dividend yield (in Dollars per share)	$0	$0

Net_Loss_Per_Share_Details

Net Loss Per Share (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Apr. 02, 2014	Dec. 31, 2013
Net Loss Per Share (Details) [Line Items]	'	'	'
Common Stock, Shares, Issued	5,545,768	5,676,414	5,366,478
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	113,580	262,686	'
Pro Forma [Member] | Unaudited pro forma assumptions [Member]	'	'	'
Net Loss Per Share (Details) [Line Items]	'	'	'
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock	18,457,235	'	'
Common Stock, Shares, Issued	149,839	'	'
Stock Issued During Period, Value, New Issues (in Dollars)	5,622,686	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	262,686	'	'
Pro Forma [Member]	'	'	'
Net Loss Per Share (Details) [Line Items]	'	'	'
Common Stock, Shares, Issued	30,091,942	'	'
Pursuant to the Underwriters' Exercise of their Over-allotment Option [Member] | Unaudited pro forma assumptions [Member]	'	'	'
Net Loss Per Share (Details) [Line Items]	'	'	'
Common Stock Shares Issued Upon Shoe Exercise	316,414	'	'
Pursuant to the Underwriters' Exercise of their Over-allotment Option [Member]	'	'	'
Net Loss Per Share (Details) [Line Items]	'	'	'
Stock Issued During Period, Value, New Issues (in Dollars)	316,414	'	'
Unaudited pro forma assumptions [Member] | Ratchet Provision Deemed Dividend [Member]	'	'	'
Net Loss Per Share (Details) [Line Items]	'	'	'
Dividends (in Dollars)	8,079,000	'	'

Net_Loss_Per_Share_Details_Sch

Net Loss Per Share (Details) - Schedule of earnings per share (USD $)	3 Months Ended			3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Apr. 02, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Apr. 02, 2014
				Upon Initial Public Offering [Member]	Pursuant to the Underwriters' Exercise of their Over-allotment Option [Member]	Ratchet Provision Deemed Dividend [Member]	Ratchet Provision Deemed Dividend [Member]
						Series G Preferred Stock [Member]	Series G Preferred Stock [Member]
Net Loss Per Share (Details) - Schedule of earnings per share [Line Items]	'	'	'	'	'	'	'
Historical net loss	($7,759,000)	($9,229,000)	'	'	'	'	'
Plus: deemed dividend on Series G Preferred Stock	'	'	'	'	'	-8,079,000	-8,079,000
Pro forma numerator for basic and diluted net loss per share attributable to common stockholders	-15,838,000	'	'	'	'	'	'
Historical denominator for basic and diluted net loss per share—weighted average shares (in Shares)	5,403,846	4,925,306	'	'	'	'	'
Plus: conversion of redeemable convertible preferred stock to common stock (in Shares)	18,457,235	'	'	'	'	'	'
Plus: automatic net exercise of a warrant (in Shares)	149,839	'	148,650	'	'	'	'
Plus: shares issued	'	'	'	5,622,686	316,414	'	'
Pro forma denominator for basic and diluted net loss per share attributable to common shareholders	29,950,020	'	'	'	'	'	'
Pro forma basic and diluted net loss per share attributable to common shareholders	($0.53)	'	'	'	'	'	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	0 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Unrecognized Tax Benefits Resulting in Net Operating Loss Carryforward	$108,000
Effective Income Tax Rate Reconciliation, Deduction, Amount	$3,317

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	3 Months Ended				0 Months Ended			3 Months Ended			0 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Apr. 02, 2014	Dec. 31, 2013	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2014	Apr. 02, 2014	Mar. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Apr. 07, 2014
				IPO [Member]	IPO [Member]	IPO [Member]	IPO [Member]	Ratchet Provision [Member]	Series G Preferred Stock [Member]	Series G Preferred Stock [Member]	Revolving Credit Facility [Member]
				Automatic Net Exercise of a Warrant [Member]	Ratchet Provision [Member]
					Series G Preferred Stock [Member]
Subsequent Events (Details) [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Proceeds from Issuance of Common Stock (in Dollars)	'	'	'	'	'	$72,019	'	'	'	'	'
Expense Related to Distribution or Servicing and Underwriting Fees (in Dollars)	'	'	'	'	'	8,325	'	'	'	'	'
Common Stock, Shares, Issued	5,545,768	5,676,414	5,366,478	149,839	'	5,676,414	'	'	'	'	'
Shares Issued, Price Per Share (in Dollars per share)	$14	'	'	'	'	$14	'	'	'	$9	'
Conversion of Stock, Shares Issued	'	'	'	'	'	18,457,235	'	'	'	'	'
Conversion of Stock, Shares Converted	18,457,235	'	'	'	577,055	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	113,580	262,686	'	'	'	262,686	'	'	'	'	'
Convertible Preferred Stock, Shares Reserved for Future Issuance	'	'	'	'	'	222,977	'	'	'	'	'
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock	'	'	'	'	'	148,650	'	577,055	'	'	'
Additional Paid in Capital, Preferred Stock (in Dollars)	'	'	'	'	'	1,140	'	'	'	'	'
Common Stock, Shares Authorized	45,000,000	'	45,000,000	'	'	'	90,000,000	'	'	'	'
Preferred Stock, Shares Authorized	27,204,144	'	27,204,144	'	'	'	10,000,000	'	3,333,333	'	'
Line of Credit Facility, Increase (Decrease), Net (in Dollars)	'	'	'	'	'	'	'	'	'	'	32,300
Line of Credit Facility, Current Borrowing Capacity (in Dollars)	'	'	'	'	'	'	'	'	'	'	$35,000